- VernacularTitle:粪菌移植治疗克罗恩病的研究进展
- Author:
Jun DU
1
;
Zhizhong XU
1
;
Zongqi HE
1
;
Shuguang ZHEN
1
;
Ke WEN
1
;
Xueliang SUN
1
Author Information
- Publication Type:Journal Article
- Keywords: Fecal microbiota transplant; Crohn′s disease; Intestinal microbiota
- From: Chinese Journal of Inflammatory Bowel Diseases 2021;05(3):229-232
- CountryChina
- Language:Chinese
- Abstract: Crohn′s disease (CD) is a refractory disease, and is lack of a perfect therapy due to the unknown pathogenesis. Dysbiosis of intestinal microbiota is closely associated with CD. It is ineffective to treat CD with one species of probiotics. In recent years, fecal microbiota transplant is an emerging therapy for CD, which may increase the diversity and abundance of intestinal bacteria of CD patients, and induce clinical response and remission.However, there are controversies on exact efficacy, timing, dosage, and way of fecal microbiota transplant because of deficiency of standard protocol.

